Amplia Therapeutics Competitors and Similar CompaniesClear all
Amplia Therapeutics's competitors and similar companies include Pharmacyclics, Black Diamond Therapeutics, RS Research and Exonate.
 Amplia Therapeutics Amplia Therapeutics is a pharmaceutical company developing Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. |  RS Research RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy. |  Exonate Exonate is a biopharmaceutical company with drug discovery programs in ophthalmology, oncology and pain. | ||
Founding Date | Founding Date 2016 | Founding Date 1991 | Founding Date 2017 | Founding Date 2015 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Melbourne, AU HQ | Locations Sunnyvale, US HQ | Locations Cambridge, US HQ Toronto, CA New York, US Stony Brook, US | Locations Epalinges, CH HQ | Locations Duxford, GB HQ |
Employees | Employees N/A | Employees 6551% decrease | Employees 2456% decrease | Employees 254% decrease | Employees 15 |
Valuation ($) | Valuation ($) 28.5 m | Valuation ($) N/A | Valuation ($) 165 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) $70m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $40.4m (FY, 2014) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $3.8m (FY, 2025) | Gross profit $689.3m (FY, 2014) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($6.6m) (FY, 2025) | Net income $86.1m (FY, 2014) | Net income $22.4m (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 202.1m | Total funding raised N/A | Total funding raised $ 11.8m |
For sources of this data, please see the company profile
View Company Profiles
Pharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company
Black Diamond Therapeutics
HQ
Cambridge, US
Employees
24
Black Diamond Therapeutics is a biotechnology company.
View companyRS Research
HQ
Epalinges, CH
Employees
25↓ 4% decrease
RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy.
View companyExonate
HQ
Duxford, GB
Employees
15
Exonate is a biopharmaceutical company with drug discovery programs in ophthalmology, oncology and pain.
View company